MustGrow Biologics Corp. (TSXV:MGRO)
Canada · Delayed Price · Currency is CAD 0.4100
-0.0400 (-8.89%)
Sep 2, 2026, 3:56 PM EST
MustGrow Biologics Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.37 | 0.92 | 3 | 6.82 | 7.02 | 9.62 |
Cash & Short-Term Investments | 4.37 | 0.92 | 3 | 6.82 | 7.02 | 9.62 |
Cash Growth | 140.20% | -69.35% | -56.03% | -2.84% | -27.07% | 190.39% |
Accounts Receivable | 1.44 | 0.07 | 0.1 | - | - | - |
Other Receivables | - | - | - | 0.09 | 0.09 | 0.06 |
Receivables | 1.44 | 0.07 | 0.1 | 0.09 | 0.09 | 0.06 |
Inventory | 0.57 | 2 | 1.43 | - | - | - |
Prepaid Expenses | 0.39 | 0.07 | 0.13 | 0.03 | 0.03 | 0.02 |
Total Current Assets | 7.16 | 3.06 | 4.66 | 6.94 | 7.13 | 9.7 |
Property, Plant & Equipment | - | 0.03 | 0.18 | - | - | - |
Other Intangible Assets | - | - | 0.58 | - | - | - |
Total Assets | 7.16 | 3.09 | 5.42 | 6.94 | 7.13 | 9.7 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.44 | 1.5 | 2.25 | 0.32 | 0.19 | 0.23 |
Accrued Expenses | - | 0.14 | 0.25 | - | 0.03 | 0.27 |
Current Portion of Long-Term Debt | 0.38 | 0.42 | 0.39 | 0.62 | 0.4 | 0.37 |
Current Portion of Leases | - | 0.01 | - | - | - | - |
Current Unearned Revenue | - | - | - | 0.27 | 0.91 | - |
Other Current Liabilities | 0.16 | - | - | - | - | - |
Total Current Liabilities | 1.97 | 2.07 | 2.9 | 1.21 | 1.54 | 0.86 |
Long-Term Debt | 0.14 | 0.13 | 0.12 | 0.14 | 0.36 | 0.38 |
Long-Term Leases | - | 0.02 | - | - | - | - |
Other Long-Term Liabilities | - | - | 0.23 | - | - | - |
Total Liabilities | 2.11 | 2.23 | 3.25 | 1.35 | 1.9 | 1.25 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 32.67 | 28.7 | 25.33 | 25.06 | 24.03 | 23.03 |
Additional Paid-In Capital | 8.85 | 7.6 | 5.01 | 3.8 | 3.82 | 2.46 |
Retained Earnings | -36.47 | -35.43 | -28.17 | -23.28 | -22.6 | -17.04 |
Shareholders' Equity | 5.05 | 0.87 | 2.17 | 5.58 | 5.24 | 8.46 |
Total Liabilities & Equity | 7.16 | 3.09 | 5.42 | 6.94 | 7.13 | 9.7 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.52 | 0.58 | 0.52 | 0.76 | 0.76 | 0.75 |
Net Cash (Debt) | 3.86 | 0.33 | 2.48 | 6.06 | 6.26 | 8.87 |
Net Cash Growth | - | -86.50% | -59.07% | -3.18% | -29.47% | 267.99% |
Net Cash Per Share | 0.06 | 0.01 | 0.05 | 0.12 | 0.13 | 0.20 |
Filing Date Shares Outstanding | 63.86 | 62.85 | 51.64 | 51.64 | 49.68 | 49.21 |
Total Common Shares Outstanding | 63.86 | 58.85 | 51.64 | 51.46 | 49.66 | 47.78 |
Working Capital | 5.19 | 0.99 | 1.76 | 5.73 | 5.59 | 8.84 |
Book Value Per Share | 0.08 | 0.01 | 0.04 | 0.11 | 0.11 | 0.18 |
Tangible Book Value | 5.05 | 0.87 | 1.59 | 5.58 | 5.24 | 8.46 |
Tangible Book Value Per Share | 0.08 | 0.01 | 0.03 | 0.11 | 0.11 | 0.18 |
Machinery | - | 0.04 | - | - | - | - |